Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Exploratory Proof of Concept Study to Assess the Pharmacokinetics/Pharmacodynamics (PK/PD) of Nemolizumab in Adult Participants With Chronic Pruritus of Unknown Origin (CPUO)

NCT07074977 is registered in ClinicalTrials.gov with Galderma R&D as lead sponsor.

NCT NCT07074977
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07074977 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Exploratory Proof of Concept Study to Assess the Pharmacokinetics/Pharmacodynamics (PK/PD) of Nemolizumab in Adult Participants With Chronic Pruritus of Unknown Origin (CPUO)
Lead sponsor
Galderma R&D
Phase
Phase 2
Overall status
Active, not recruiting
Start date
October 20, 2025
Completion date
January 31, 2027
Enrollment
50 (estimated)
Sites
26

Conditions

As the registry lists them; a condition with its own page is linked.

chronic pruritus of unknown origin